Physician and site support are critical for the success of rare disease clinical trials, where patient involvement can be limited. Effective training, ongoing support, and reducing the burdens on investigators are key to enhancing trial efficiency and patient care. Strengthening the relationship between sponsors and sites ultimately leads to better trial outcomes and improved patient experiences.
